Non-Polio enterovirus infections pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 14: Line 14:


===[[Rhinoviruses]]===
===[[Rhinoviruses]]===
* Exclusively affects the [[epithelial]] layer of the airways
* The mechanisms of uptake into cell include [[endocytosis]] and [[pinocytosis]] depending on the host and the [[virus]] type.
*On entry into the [[cell]], the [[virion]] induces a [[conformational]] change by lowering the [[pH]] of the [[endosome]] or altering the [[receptor]] [[binding]].  This results in the exposure of [[hydrophobic]] domains and pore-mediated release of the [[viral]] particles into the [[cytoplasm]] of the [[genome]], marking the beginning of [[viral]] [[polyprotein]] [[synthesis]] by the host [[cells]].
* They do not participate in direct [[cell]] destruction, instead disrupting the [[epithelial]] [[barriers]] by stimulating [[Reactive oxygen species]] during their [[replication]] and dissociating [[zona occludens-1]] from the [[tight junction]] complex. This triggers the release of [[cytokines]], that activate [[granulocytes]], [[monocytes]] and [[dendritic]] [[cells]]. [[IgG]] and [[IgA]] response takes about 1 to 2 weeks, usually after the [[virus]] has been eliminated but is crucial in preventing [[re-inoculation]]. Levels may remain high till a year after, but do not exhibit [[cross-reactivity]] among [[serotypes]]. On the contrary, [[viral]] load can indicate [[severity]] of the [[disease]].
* In infants, [[rhinoviruses]] damage the [[respiratory]] [[cells]] and damage the [[immune response]]. They are an independent risk factor for the development of [[asthma]] and recurrent [[wheezing]].
* In adults, they are the most common causes of [[acute]] [[exacerbations]] of [[COPD]], necessitating [[hospital]] stays. They also contribute to abut two-thirds of [[viral]] upper [[respiratory]] tract [[infections]]-associated [[asthma]] [[exacerbations]].
== References ==
== References ==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 18:58, 4 February 2023

Non-Polio enterovirus infections Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Polio enterovirus infections from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non-Polio enterovirus infections pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-Polio enterovirus infections pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-Polio enterovirus infections pathophysiology

CDC on Non-Polio enterovirus infections pathophysiology

Non-Polio enterovirus infections pathophysiology in the news

Blogs on Non-Polio enterovirus infections pathophysiology

Directions to Hospitals Treating Non-Polio enterovirus infections

Risk calculators and risk factors for Non-Polio enterovirus infections pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: {Sujaya}}

Overview

The cellular uptake of enteorviruses is mediated by receptor molecules such as, intracellular adhesion molecule-1 (ICAM-1), low-density lipoprotein receptor (LDL-R), and non-protein factors such as heparan sulfate and sialic acid. Incubation periods range from 12 hours to 5 days, with experimental volunteers reporting symptoms several hours after aritficial inoculation.

Pathophysiology

Non-polio non-rhinovirus enteroviruses

Rhinoviruses

References


Template:WikiDoc Sources